tiprankstipranks
Krystal Biotech, Inc. (KRYS)
NASDAQ:KRYS
US Market
KRYS
Krystal Biotech
RESEARCH TOOLSreports
Want to see KRYS full AI Analyst Report?

Krystal Biotech (KRYS) Ratios

691 Followers

Krystal Biotech Ratios

KRYS's free cash flow for Q1 2026 was $0.95. For the 2026 fiscal year, KRYS's free cash flow was decreased by $ and operating cash flow was $0.46. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 9.46 9.95 7.28 17.76 13.30
Quick Ratio
 9.06 9.56 7.02 17.55 13.30
Cash Ratio
 4.65 4.82 3.38 10.83 5.61
Solvency Ratio
 1.93 1.85 0.88 0.42 -3.77
Operating Cash Flow Ratio
 2.32 1.95 1.21 -2.68 -3.49
Short-Term Operating Cash Flow Coverage
 139.04 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 899.50M$ 910.37M$ 632.59M$ 548.20M$ 347.56M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.02
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 0.01 0.02
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.09 1.09 1.12 1.05 1.07
Debt Service Coverage Ratio
 112.87 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.06 0.32 0.25 0.30 0.35
Net Debt to EBITDA
 -2.69 -2.90 -3.07 3.84 1.31
Profitability Margins
Gross Profit Margin
92.79%92.61%93.09%93.90%0.00%
EBIT Margin
42.85%41.45%35.52%-191.77%0.00%
EBITDA Margin
44.44%43.13%37.83%-180.11%0.00%
Operating Profit Margin
42.85%41.45%22.61%-216.43%0.00%
Pretax Profit Margin
49.68%48.69%32.82%25.44%0.00%
Net Profit Margin
53.92%52.64%30.69%21.56%0.00%
Continuous Operations Profit Margin
53.92%52.64%30.69%21.56%0.00%
Net Income Per EBT
108.54%108.11%93.50%84.76%100.00%
EBT Per EBIT
115.94%117.47%145.15%-11.75%96.40%
Return on Assets (ROA)
16.11%15.36%8.44%1.34%-25.06%
Return on Equity (ROE)
19.25%16.80%9.42%1.40%-26.80%
Return on Capital Employed (ROCE)
13.87%13.10%6.89%-13.97%-27.42%
Return on Invested Capital (ROIC)
13.85%13.09%6.43%-11.82%-27.34%
Return on Tangible Assets
16.11%15.36%8.44%1.34%-25.06%
Earnings Yield
2.49%2.87%1.99%0.32%-6.93%
Efficiency Ratios
Receivables Turnover
 3.29 3.05 2.77 1.21 0.00
Payables Turnover
 7.35 8.89 4.02 1.67 0.00
Inventory Turnover
 0.71 0.71 0.76 0.44 0.00
Fixed Asset Turnover
 2.60 2.46 1.80 0.30 0.00
Asset Turnover
 0.30 0.29 0.28 0.06 0.00
Working Capital Turnover Ratio
 0.46 0.50 0.49 0.11 0.00
Cash Conversion Cycle
 579.15 591.89 523.20 908.56 0.00
Days of Sales Outstanding
 111.10 119.52 131.60 302.66 0.00
Days of Inventory Outstanding
 517.69 513.45 482.30 824.02 0.00
Days of Payables Outstanding
 49.64 41.08 90.70 218.13 0.00
Operating Cycle
 628.79 632.97 613.90 1.13K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 8.55 6.94 4.32 -3.27 -3.95
Free Cash Flow Per Share
 8.11 6.53 4.17 -3.70 -6.02
CapEx Per Share
 0.44 0.41 0.15 0.43 2.08
Free Cash Flow to Operating Cash Flow
 0.95 0.94 0.97 1.13 1.53
Dividend Paid and CapEx Coverage Ratio
 19.41 16.81 29.12 -7.53 -1.90
Capital Expenditure Coverage Ratio
 19.41 16.81 29.12 -7.53 -1.90
Operating Cash Flow Coverage Ratio
 139.04 21.51 17.00 -10.97 -11.26
Operating Cash Flow to Sales Ratio
 0.60 0.52 0.42 -1.75 0.00
Free Cash Flow Yield
2.61%2.65%2.66%-2.99%-7.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 39.27 34.84 50.24 308.15 -14.43
Price-to-Sales (P/S) Ratio
 21.32 18.34 15.42 66.45 0.00
Price-to-Book (P/B) Ratio
 6.92 5.85 4.73 4.33 3.87
Price-to-Free Cash Flow (P/FCF) Ratio
 37.47 37.77 37.58 -33.49 -13.15
Price-to-Operating Cash Flow Ratio
 35.31 35.53 36.29 -37.93 -20.08
Price-to-Earnings Growth (PEG) Ratio
 0.49 0.27 0.07 -2.87 -0.19
Price-to-Fair Value
 6.92 5.85 4.73 4.33 3.87
Enterprise Value Multiple
 45.28 39.61 37.68 -33.06 -15.98
Enterprise Value
 8.61B 6.65B 4.14B 3.02B 1.87B
EV to EBITDA
 46.43 39.61 37.68 -33.06 -15.98
EV to Sales
 20.63 17.09 14.26 59.54 0.00
EV to Free Cash Flow
 36.27 35.20 34.75 -30.00 -12.16
EV to Operating Cash Flow
 34.40 33.10 33.56 -33.99 -18.56
Tangible Book Value Per Share
 43.59 42.14 33.10 28.68 20.49
Shareholders’ Equity Per Share
 43.59 42.14 33.10 28.68 20.49
Tax and Other Ratios
Effective Tax Rate
 -0.09 -0.08 0.06 0.15 0.00
Revenue Per Share
 14.25 13.44 10.16 1.87 0.00
Net Income Per Share
 7.68 7.08 3.12 0.40 -5.49
Tax Burden
 1.09 1.08 0.94 0.85 1.00
Interest Burden
 1.16 1.17 0.92 -0.13 1.16
Research & Development to Revenue
 0.14 0.15 0.18 0.92 0.00
SG&A to Revenue
 0.37 0.38 0.39 0.00 0.00
Stock-Based Compensation to Revenue
 0.07 0.14 0.17 0.79 0.00
Income Quality
 1.11 0.98 1.38 -8.12 0.72
Currency in USD